Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VCYT
#1443
Veracyte, Inc.
36.590
0
-1.25%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-1.25%
Monthly Change
-8.13%
6 month change
-0.84%
Year Change
-0.84%
Previous Close
37.055
0
Open
36.590
0
Bid
Ask
Low
36.590
0
High
36.590
0
Volume
138
Markets
US Stock Market
Healthcare
VCYT
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
77.5 M
77.94 M
78.31 M
78.67 M
79.05 M
79.46 M
—
Valuation ratios
Enterprise value
2.36 B
2.85 B
2.14 B
1.91 B
2.4 B
2.98 B
9.42 B
Price to earnings ratio
-261.85
127.74
68.95
77.23
88.03
51.34
285.55
Price to sales ratio
6.07
6.94
5.02
4.44
5.48
—
—
Price to cash flow ratio
39.27
41.22
32.46
22.69
25.04
24.89
105.07
Price to book ratio
0.58
2.63
0.5
0.45
0.56
2.59
4.09
Enterprise value to EBITDA ratio
—
8.65
6.49
5.89
7.08
—
—
Profitability ratios
Return on assets %
0.01
0
0.01
-0
0.01
0.03
0.05
Return on equity %
0.01
0
0.01
-0
0.01
0.03
0.05
Return on invested capital %
1.03
-6.41
1.08
0.15
4.75
10.98
16.96
Gross margin %
68.19
66.39
69.46
68.97
69.22
72.51
280.15
Operating margin %
2.33
3.52
2.54
-0.41
9.41
18.96
30.49
EBITDA margin %
76.94
65.52
70.1
59.06
78.75
80.11
288.01
Net margin %
9.86
4.31
6.16
-0.75
13.03
27.87
46.29
Liquidity ratios
Quick ratio
4.79
4.46
4.78
5.1
5.94
7.81
23.63
Current ratio
5.08
4.73
5.1
5.43
6.23
8.15
24.9
Inventory turnover
0.15
0.13
0.11
0.11
0.12
0.13
0.47
Asset turnover
0.09
0.09
0.09
0.1
0.1
0.1
0.38
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.39
0.31
0.07
0.42
0.56
0.65
1.7
EBIT per share
1.08
0.91
0.94
0.89
1.23
1.33
4.39
EBITDA per share
1.15
0.99
1
0.96
1.3
1.4
4.66
Total debt per share
—
—
—
—
—
—
—
Cash per share
3.54
3.7
2.32
2.75
3.95
4.5
13.52
Net current asset value per share
4.61
4.76
4.79
5.19
5.62
6.06
21.66
Tangible book value per share
3.94
4.19
4.27
4.4
4.98
5.63
19.27
Working capital per share
3.7
3.76
3.85
4.23
4.72
5.32
18.11
Book value per share
15.21
15.05
14.93
15.28
15.73
16.25
62.19
News
GEHC & UCSF Form 10-Year Alliance to Advance Imaging & Care Delivery
GEHC Unveils AI LOGIQ Ultrasound Systems to Boost Imaging & Workflow
Veracyte Q4 Earnings Beat Estimates, Revenues Grow Y/Y, Stock Rises
Veracyte stock price target raised to $48 by Needham on growth
Veracyte (VCYT) Q4 Earnings and Revenues Surpass Estimates
Veracyte Q4 2025 slides: 19% revenue growth, profitability soars
Merit Medical Q4 Earnings & Revenues Beat Estimate, Margins Expand
FMS Stock Rises as Q4 Earnings & Sales Beat Estimates, Margins Expand
Stryker Launches Synchfix EVT for Flexible Syndesmotic Fixation
BD Launches Urine Complete Cup Kit for Smarter Testing & Accuracy
AxoGen (AXGN) Q4 Earnings Miss Estimates
ANGO Expands NanoKnife in Europe for Multi-Organ Tumor Ablation